TITLE

Ipilimumab had dose-dependent effect in treatment of advanced melanoma

PUB. DATE
January 2010
SOURCE
Hem/Onc Today;1/25/2010, Vol. 11 Issue 2, p32
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article focuses on a phase-2 trial that found that ipilimumab demonstrated a dose-depended effect in patients with advanced melanoma.
ACCESSION #
47607826

 

Related Articles

  • Using Mind over Metastatic Melanoma Increases Cancer Survival. Watson, Fiona // Dermatology Times;Oct97, Vol. 18 Issue 10, p70 

    Looks into the possibility that psychological factors can influence survival of cancer patients diagnosed with metastatic melanoma. Examination of the patient's emotional adjustment and coping mechanisms; Treatment expectations; Predictors for disease survival.

  • The Clone Ranger? Heslop, Helen E; Brenner, Malcolm K // Molecular Therapy;Sep2008, Vol. 16 Issue 9, p1520 

    The author comments on an article which describes a T-lymphocyte cell clone that eradicated melanoma in a patient with advanced metastatic disease. He said that although the obliteration of melanoma using a single T-lymphocyte clone is of considerable value and interest, there is still a need to...

  • LM management: Topical agent option for malignant melanoma. Guttman, Cheryl // Dermatology Times;May2009 Supplement 3, Vol. 30, p3 

    The article focuses on the dual therapy for the treatment of two patients with invasive malignant melanoma surrounded by lentigo maligna (LM) involving limited surgical expression followed by topical application of imiquimod 5 percent cream in the U.S. It states that the treatment could...

  • Vemurafenib improved OS, PFS in V600EBRAF mutated melanoma. Wen-Jen Hwu // Hem/Onc Today;7/25/2011, Vol. 12 Issue 14, p24 

    The article discusses the use of vemurafenib in treating patients with advanced melanoma.

  • Hepatic vascular lesions associated with dacarbazine treatment. Greenstone, M.A.; Dowd, Pauline M.; Mikhailidis, D.P.; Scheuer, P.J. // British Medical Journal (Clinical Research Edition);5/30/1981, Vol. 282 Issue 6278, p1744 

    Investigates the use of dacarbazine in the treatment of melanoma among patients with acute liver failure undergoing chemotherapy in Great Britain. Side-effects of the drug; Development of hepatic vascular lesions during treatment with dacarbazine; Deaths of patients after hepatic vascular...

  • Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme. Sileni, Vanna Chiarion; Pigozzo, Jacopo; Ascierto, Paolo Antonio; Maria Grimaldi, Antonio; Maio, Michele; Di Guardo, Lorenza; Marchetti, Paolo; de Rosa, Francesco; Nuzzo, Carmen; Testori, Alessandro; Cocorocchio, Emilia; Bernengo, Maria Grazia; Guida, Michele; Marconcini, Riccardo; Merelli, Barbara; Parmiani, Giorgio; Rinaldi, Gaetana; Aglietta, Massimo; Grosso, Marco; Queirolo, Paola // Journal of Experimental & Clinical Cancer Research (17569966);2014, Vol. 33 Issue 1, p1 

    Background Elderly patients with metastatic melanoma have different disease characteristics and a poorer prognosis than younger patients. Data from clinical trials and expanded access programmes (EAPs) suggest ipilimumab confers a consistent survival benefit and has a similar safety profile...

  • Forum.  // Pharmaceutical Medicine - New Zealand;2012, Vol. 26 Issue 4, p257 

    The article presents abstracts of articles within the issue including the health care reform forged by Massachusetts, the relation of patient satisfaction to resource use and costs and the variability in costs for advanced melanoma.

  • There's Always a Chance: Grigore Burcus' Cancer Experience. Sanchez, Daniel // Gerson Healing Newsletter;May/Jun2013, Vol. 28 Issue 3, p1 

    The author presents a personal narrative of his experience using the Gerson Therapy, which is a holistic treatment for cancer from non-profit organization, the Gerson Institute, with topics including his diagnosis of malignant melanoma, its metastasis to his lungs, and his treatment regimen.

  • Surgical margins for melanoma in situ.  // Current Medical Literature: Dermatology;2012, Vol. 17 Issue 2, p51 

    The article presents a study which investigates the surgical margins of melanoma in situ. The study reviewed a series of 1120 Mohs micrographic surgeries that were performed in 1072 patients. Results show that a recommended five millimeter (mm) margin is inadequate for melanoma, hence, nine mm...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics